Dark
Streaming/Mobile
Old Site
Home
Daily
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
17:37:51 EDT Tue 28 Mar 2023
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:ALBO from 2022-03-29 to 2023-03-28 - 39 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2023-02-14 08:30
U
U:ALBO
News Release
200
FDA Grants June 15, 2023 PDUFA Date to Albireo for Bylvay ‚ ® in Alagille Syndrome
2022-12-20 16:30
U
U:ALBO
News Release
200
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2022-12-19 08:30
U
U:ALBO
News Release
200
Albireo Submits Bylvay ‚ ® Alagille Syndrome Regulatory Filings to FDA and EMA
2022-12-06 16:30
U
U:ALBO
News Release
200
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2022-12-06 08:30
U
U:ALBO
News Release
200
Albireo Appoints Paul Streck, M.D., as Chief Medical Officer & ‚ Craig Hopkinson, M.D., to Board of Directors
2022-11-09 08:30
U
U:ALBO
News Release
200
Albireo to Participate in Jefferies London Healthcare Conference
2022-11-08 16:01
U
U:ALBO
News Release
200
Albireo Reports Q3 2022 Financial Results and Business Update
2022-11-07 08:30
U
U:ALBO
News Release
200
Bylvay(TM) (odevixibat) Data Presented at AASLD The Liver Meeting(TM) 2022, Demonstrating Native Liver Survival in Children Across PFIC Types
2022-11-03 08:30
U
U:ALBO
News Release
200
Albireo Announces 2022 SPARK Grant Winners
2022-11-02 08:30
U
U:ALBO
News Release
200
Albireo Completes Phase 3 BOLD Study Enrollment of Bylvay(R) in Biliary Atresia
2022-11-01 08:30
U
U:ALBO
News Release
200
Albireo to Present Late Breaking Bylvay(TM) (odevixibat) Data at AASLD 2022
2022-10-31 08:30
U
U:ALBO
News Release
200
Albireo to Report Q3 2022 Financial Results on November 8, 2022
2022-10-13 08:30
U
U:ALBO
News Release
200
Albireo Presents Data on Greater Efficacy in PFIC with Earlier Bylvay(TM) Treatment at NASPGHAN
2022-10-12 08:30
U
U:ALBO
News Release
200
Albireo to Participate in H.C. Wainwright 3rd Annual Hepatitis B Virus (HBV) Conference
2022-10-11 07:00
U
U:ALBO
News Release
200
Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay(TM) (odevixibat) in Alagille Syndrome
2022-10-05 08:30
U
U:ALBO
News Release
200
Albireo to Showcase New Data at AASLD The Liver Meeting(TM) 2022
2022-09-27 16:30
U
U:ALBO
News Release
200
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2022-09-22 08:30
U
U:ALBO
News Release
200
Albireo Announces $115 Million Royalty Monetization Agreement with Sagard
2022-09-20 08:00
U
U:ALBO
News Release
200
Albireo to Participate in Guggenheim Nantucket Therapeutics Conference
2022-09-06 08:00
U
U:ALBO
News Release
200
Italian Medicines Agency Approves Reimbursed Access to Bylvay(TM) (odevixibat) For Patients with All PFIC Types
2022-09-01 08:00
U
U:ALBO
News Release
200
Albireo to Participate in Upcoming Investor Conferences
2022-08-22 17:13
U
U:ALBO
News Release
200
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2022-08-15 16:05
U
U:ALBO
News Release
200
Albireo Reports Q2 2022 Financial Results and Business Update
2022-08-10 08:30
U
U:ALBO
News Release
200
Albireo Appoints New Members to Board of Directors
2022-08-03 08:30
U
U:ALBO
News Release
200
Albireo to Participate in 2022 Wedbush PacGrow Healthcare Conference
2022-08-01 08:30
U
U:ALBO
News Release
200
Albireo to Report Q2 2022 Financial Results on August 15, 2022
2022-07-26 16:30
U
U:ALBO
News Release
200
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2022-07-06 08:30
U
U:ALBO
News Release
200
The Lancet Gastroenterology & Hepatology Publishes Data from Albireo's Landmark PEDFIC 1 Study of Bylvay(TM) (odevixibat) Treatment in PFIC
2022-06-30 08:00
U
U:ALBO
News Release
200
Albireo to Present at the William Blair Biotech Focus Conference 2022
2022-06-24 08:30
U
U:ALBO
News Release
200
Albireo Presents New Bylvay(TM) (odevixibat) Data at Annual ESPGHAN Congress
2022-06-23 08:30
U
U:ALBO
News Release
200
Albireo Announces Presentation of New Data in Pediatric and Adult Liver Diseases
2022-06-08 08:30
U
U:ALBO
News Release
200
Albireo to Present New Data at the EASL International Liver Congress(TM) 2022
2022-06-07 08:30
U
U:ALBO
News Release
200
Albireo to Present New Data at the 54th Annual Meeting of ESPGHAN
2022-06-02 16:30
U
U:ALBO
News Release
200
Albireo to Participate at Upcoming Investor Conferences
2022-05-23 08:30
U
U:ALBO
News Release
200
Albireo Presented Data in Cholestatic Liver Diseases at Digestive Disease Week (DDW) 2022
2022-05-19 16:30
U
U:ALBO
News Release
200
Albireo to Participate in the H.C. Wainwright Global Investment Conference 2022
2022-05-16 16:01
U
U:ALBO
News Release
200
Albireo Reports Q1 2022 Financial Results and Business Update
2022-05-09 08:30
U
U:ALBO
News Release
200
Albireo to Report Q1 2022 Financial Results on May 16
2022-03-29 08:30
U
U:ALBO
News Release
200
Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Syndrome